A Pilot Study to Improve Preventive Asthma Care for Urban Adolescents

NCT ID: NCT01106326

Last Updated: 2014-08-01

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 30 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2009-09-30
• Study Completion Date: 2012-09-30

Brief Summary

The goal of this pilot study is to implement directly observed therapy with preventive asthma medications through a partnership with the school nurse (with input and direction from the primary care provider) to assure that the teen receives guideline based preventive medications, and provide a motivational interviewing intervention to help the teen transition to independence with their medical treatment plan. We hypothesize that this community-based pilot intervention will; 1) be feasible and acceptable among this population and among school personnel, and 2) yield reduced asthma morbidity (symptom-free days, absenteeism, and emergency room / urgent care use for asthma care). We anticipate that enhancing preventive healthcare for urban teens with asthma through partnerships with schools will yield improved health, prevention of suffering, decreased absenteeism from school, and reduced healthcare costs. This new method of preventive care delivery could be sustained within the school nursing system, and could be implemented in schools nationwide. Further, it could be applied to other chronic illnesses affecting disadvantaged populations.

Conditions

Asthma

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: HEALTH_SERVICES_RESEARCH
• Blinding Strategy: NONE

Study Groups

Intervention

Teens participating in this study will have:

1. directly observed administration of their daily preventive asthma medication at school, by the school nurse, for the first 6-8 weeks of the study

2. three counseling sessions with a study nurse trained in principles of motivational interviewing (MI), that are designed to enhance the teen's motivation to change health behaviors, with a focus on adherence to evidence-based preventive care guidelines (e.g.; preventive medications).

Group Type: EXPERIMENTAL

Intervention

Intervention Type: BEHAVIORAL

Teens participating in this study will have:

1. directly observed administration of their daily preventive asthma medication at school, by the school nurse, for the first 6-8 weeks of the study

2. three counseling sessions with a study nurse trained in principles of motivational interviewing (MI), that are designed to enhance the teen's motivation to change health behaviors, with a focus on adherence to evidence-based preventive care guidelines (e.g.; preventive medications).

Interventions

Intervention

Teens participating in this study will have:

1. directly observed administration of their daily preventive asthma medication at school, by the school nurse, for the first 6-8 weeks of the study

2. three counseling sessions with a study nurse trained in principles of motivational interviewing (MI), that are designed to enhance the teen's motivation to change health behaviors, with a focus on adherence to evidence-based preventive care guidelines (e.g.; preventive medications).

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• Physician-diagnosed asthma
• Persistent asthma (criteria based on NHLBI guidelines).
• Age >12 and <15 years.
• Attending school in the Rochester City School District.
• Signed physician permission to enroll the child.
• Current prescription of a daily preventive asthma medication
• Parent or caregiver and the adolescent must consent to the intervention.

Exclusion Criteria

• Inability to speak and understand English.
• No access to a working phone for follow-up surveys
• The family planning to leave the school district within fewer than 6 months.
• The teen having other significant medical conditions
• The teen having a diagnosed developmental condition per parent report.
• Adolescents in foster care or other situations in which consent cannot be obtained from a guardian.
• Adolescents that were previously enrolled in our School-Based Asthma Study

• Minimum Eligible Age: 12 Years
• Maximum Eligible Age: 15 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

National Institutes of Health (NIH)

NIH

Sponsor Role: collaborator

University of Rochester

OTHER

Sponsor Role: lead

Responsible Party

Jill Halterman

Associate Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Jill S. Halterman, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

University of Rochester

Locations

University of Rochester

Rochester, New York, United States

Countries

United States

References

Blaakman SW, Cohen A, Fagnano M, Halterman JS. Asthma medication adherence among urban teens: a qualitative analysis of barriers, facilitators and experiences with school-based care. J Asthma. 2014 Jun;51(5):522-9. doi: 10.3109/02770903.2014.885041. Epub 2014 Feb 7.

Reference Type: BACKGROUND

PMID: 24494626 (View on PubMed)

Halterman JS, Riekert K, Bayer A, Fagnano M, Tremblay P, Blaakman S, Borrelli B. A pilot study to enhance preventive asthma care among urban adolescents with asthma. J Asthma. 2011 Jun;48(5):523-30. doi: 10.3109/02770903.2011.576741.

Reference Type: RESULT

PMID: 21599562 (View on PubMed)

Other Identifiers

28198

Identifier Type: -

Identifier Source: org_study_id